Follow
Eric Lader
Eric Lader
VP, R&D
Verified email at qiagen.com
Title
Cited by
Cited by
Year
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study
P Mestdagh, N Hartmann, L Baeriswyl, D Andreasen, N Bernard, C Chen, ...
Nature methods 11 (8), 809-815, 2014
6632014
Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method
D Enderle, A Spiel, CM Coticchia, E Berghoff, R Mueller, ...
PloS one 10 (8), e0136133, 2015
3622015
Methods and reagents for preserving RNA in cell and tissue samples
ES Lader
US Patent 6,204,375, 2001
2042001
Concise gene signature for point‐of‐care classification of tuberculosis
J Maertzdorf, G McEwen, J Weiner 3rd, S Tian, E Lader, U Schriek, ...
EMBO molecular medicine 8 (2), 86-95, 2016
1372016
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury
ADB Vliegenthart, JM Shaffer, JI Clarke, LEJ Peeters, A Caporali, ...
Scientific reports 5 (1), 15501, 2015
1352015
tctex-1: a candidate gene family for a mouse t complex sterility locus
E Lader, HS Ha, M O'Neill, K Artzt, D Bennett
Cell 58 (5), 969-979, 1989
1331989
Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus
B Zheng, Y Guan, Q Tang, D Cheng, FY Xie, ML He, KW Chan, KL Wong, ...
Antiviral therapy 9 (3), 365-374, 2004
1312004
Oocyte-specific factors bind a conserved upstream sequence required for mouse zona pellucida promoter activity
SE Millar, E Lader, LF Liang, J Dean
Molecular and cellular biology, 1991
811991
A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v …
P Besmer, E Lader, PC George, PJ Bergold, FH Qiu, EE Zuckerman, ...
Journal of virology 60 (1), 194-203, 1986
621986
ZAP-1 DNA binding activity is first detected at the onset of zona pellucida gene expression in embryonic mouse oocytes
SE Millar, ES Lader, J Dean
Developmental biology 158 (2), 410-413, 1993
481993
Modulating the efficiency of nucleic acid amplification reactions with 3'modified oligonucleotides
ES Lader, M Goldrick, M Winkler
US Patent 6,057,134, 2000
462000
Method for the reverse transcription and/or amplification of nucleic acids
T Wille, C Korfhage, E Lader
US Patent App. 10/565,989, 2006
392006
miRNA profiling from blood—challenges and recommendations
J Shaffer, M Schlumpberger, E Lader
Qiagen Scientific article, 1-10, 2012
282012
Multiplexing siRNAs to compress RNAi-based screen size in human cells
SE Martin, TL Jones, CL Thomas, PL Lorenzi, DA Nguyen, T Runfola, ...
Nucleic acids research 35 (8), e57, 2007
282007
Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform
A Darwanto, AM Hein, S Strauss, Y Kong, A Sheridan, D Richards, ...
BMC cancer 17, 1-8, 2017
242017
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions
B Gong, D Li, R Kusko, N Novoradovskaya, Y Zhang, S Wang, ...
Genome biology 22, 1-23, 2021
212021
Is there abrachyury the second? Analysis of a transgenic mutation involved in notochord maintenance in mice
GM Rennebeck, E Lader, Q Chen, RA Bohm, ZS Cai, C Faust, ...
Developmental biology 172 (1), 206-217, 1995
191995
Definitive chromosomal location of the H-2 complex by in situ hybridization to pachytene chromosomes
E Lader, BT Clark, SC Jhanwar, RSK Chaganti, D Bennett
Immunogenetics 22, 49-54, 1985
191985
Epidermal growth-factor–induced transcript isoform variation drives mammary cell migration
WJ Koestler, A Zeisel, C Koerner, JM Tsai, J Jacob-Hirsch, N Ben-Chetrit, ...
PLoS One 8 (12), e80566, 2013
172013
Mouse Brachyury the Second (T2) is a gene next to classical T and a candidate gene for tct
G Rennebeck, E Lader, A Fujimoto, EP Lei, K Artzt
Genetics 150 (3), 1125-1131, 1998
161998
The system can't perform the operation now. Try again later.
Articles 1–20